Article révisé par les pairs
Résumé : Hepatitis C virus (HCV) infection is associated with reduced patient survival following combined liver-kidney transplantation (LKT). The aim of this study was to assess the efficacy and safety of second-generation direct-acting antivirals (DAAs) in this difficult-to-treat population. The ANRS CO23 “Compassionate use of Protease Inhibitors in Viral C Liver Transplantation” (CUPILT) study is a prospective cohort including transplant recipients with recurrent HCV infection treated with DAAs. The present work focused on recipients with recurrent infection following LKT. The study population included 23 patients. All patients received at least one NS5B inhibitor (sofosbuvir) in their antiviral regimen an average of 90 months after LKT. Ninety-six percent of recipients achieved a sustained virological response (SVR) at week 12 (SVR12). In terms of tolerance, 39% of recipients presented with at least one serious adverse event. None of the patients experienced acute rejection during therapy and there were no deaths during follow-up. The glomerular filtration rate (GFR) decreased significantly from baseline to the end of therapy. However, this study did not show that the decline in GFR persisted over time or that it was directly related to DAAs. The DAA-based regimen is well tolerated with excellent results in terms of efficacy. It will become the gold standard for the treatment of recurrent HCV following LKT.

Documents en relation

DI-fusion

  • Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference
    par Mouna, Lina , Rossignol, Emilie , Tateo, Mariagrazia , Coilly, Audrey , Duclos-Vallée, Jean-Charles , Duvoux, Christophe , Durand, François , Tran, Albert , Radenne, Sylvie , Canva-Delcambre, Valérie , Houssel-Debry, Pauline , Dumortier, Jérôme , Conti, Filomena , De Ledinghen, Victor , Leroy, Vincent , Kamar, Nassim , Di Martino, Vincent , Moreno, Christophe , Botta-Fridlund, Danielle , D'Alteroche, Louis , Lebray, Pascal , Perre, Philippe , Besch, Camille , Silvain, Christine , Habersetzer, François , Debette-Gratien, Maryline , Abergel, Armando , Diallo, Alpha , Samuel, Didier , Roque-Afonso, Anne Marie , Pageaux, Georges-Philippe
    Publication 2019-06-01
  • 12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation
    par Houssel-Debry, Pauline , Coilly, Audrey , Fougerou-Leurent, Claire , Jezequel, Caroline , Duvoux, Christophe , De Ledinghen, Victor , Radenne, Sylvie , Kamar, Nassim , Leroy, Vincent , Martino, Vincent Di , D'Alteroche, Louis , Canva, Valérie , Conti, Filomena , Dumortier, Jérôme , Montialoux, Hélène , Lebray, Pascal , Botta-Fridlund, Danielle , Tran, Albert , Moreno, Christophe , Silvain, Christine , Besch, Camille , Perre, Philippe , Francoz, Claire , Abergel, Armando , Habersetzer, François , Debette-Gratien, Maryline , Cagnot, Carole , Diallo, Alpha , Chevaliez, Stéphane , Rossignol, Emilie , Veislinger, Aurélie , Duclos-Vallée, Jean-Charles , Pageaux, Georges-Philippe
    Publication 2018-10-01
  • Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation
    par Dumortier, Jérôme , Canva, Valérie , Di Martino, Vincent , Conti, Filomena , Kamar, Nassim , Moreno, Christophe , Lebray, Pascal , Tran, Albert , Besch, Camille , Diallo, Mamadou Alpha , Rohel, Alexandra , Leroy, Vincent , Rossignol, Emilie , Abergel, Armando , Botta-Fridlund, Danielle , Coilly, Audrey , Samuel, Didier , Duclos-Vallée, Jean-Charles , Pageaux, Georges-Philippe , Duvoux, Christophe , De Ledinghen, Victor , Francoz, Claire , Houssel-Debry, Pauline , Radenne, Sylvie , D'Alteroche, Louis , Fougerou-Leurent, Claire
    Publication 2016-10
  • Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study
    par Coilly, Audrey , Leroy, Vincent , Canva, Valérie , Lebray, Pascal , Moreno, Christophe , Dumortier, Jérôme , Silvain, Christine , Besch, Camille , Perre, Philippe , Botta-Fridlund, Danielle , Anty, Rodolphe , Fougerou-Leurent, Claire , Francoz, Claire , Abergel, Armando , Debette-Gratien, Maryline , Conti, Filomena , Habersetzer, François , Rohel, Alexandra , Rossignol, Emilie , Danjou, Hélène , Roque-Afonso, Anne Marie , Samuel, Didier , De Ledinghen, Victor , Duclos-Vallée, Jean-Charles , Pageaux, Georges-Philippe , Houssel-Debry, Pauline , Duvoux, Christophe , Di Martino, Vincent , Radenne, Sylvie , Kamar, Nassim , D'Alteroche, Louis
    Publication 2016-10
  • Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort
    par Barrail-Tran, Aurélie , Goldwirt, Lauriane , Gelé, Thibaut , Laforest, Claire , Lavenu, Audrey , Danjou, Hélène , Radenne, Sylvie , Leroy, Vincent , Houssel-Debry, Pauline , Duvoux, Christophe , Kamar, Nassim , De Ledinghen, Victor , Canva, Valérie , Conti, Filomena , Durand, François , D’Alteroche, Louis , Botta-Fridlund, Danielle , Moreno, Christophe , Cagnot, Carole , Samuel, Didier , Fougerou-Leurent, Claire , Pageaux, Georges-Philippe , Duclos-Vallée, Jean-Charles , Taburet, Anne Marie , Coilly, Audrey
    Publication 2019-04-01